Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to $28.1 million.

  • Caribou Biosciences' Total Current Liabilities fell 1275.23% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year decrease of 1275.23%. This contributed to the annual value of $30.7 million for FY2024, which is 829.98% up from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' Total Current Liabilities is $28.1 million, which was down 1275.23% from $28.9 million recorded in Q2 2025.
  • Over the past 5 years, Caribou Biosciences' Total Current Liabilities peaked at $34.4 million during Q2 2023, and registered a low of $24.6 million during Q3 2023.
  • Moreover, its 5-year median value for Total Current Liabilities was $28.4 million (2023), whereas its average is $28.5 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 10848.33% in 2021, then tumbled by 1472.2% in 2023.
  • Over the past 5 years, Caribou Biosciences' Total Current Liabilities (Quarter) stood at $25.8 million in 2021, then rose by 8.9% to $28.1 million in 2022, then rose by 0.62% to $28.3 million in 2023, then grew by 8.3% to $30.7 million in 2024, then fell by 8.46% to $28.1 million in 2025.
  • Its Total Current Liabilities stands at $28.1 million for Q3 2025, versus $28.9 million for Q2 2025 and $28.5 million for Q1 2025.